Concerns about data privacy abound as we head into the final quarter of 2018. Large-scale data breaches at hospitals, banks, retailers, and other organizations — and on social media platforms like Facebook — have most Americans, including lawmakers, thinking about how best to protect their personal information.
In response, several states have been creating or fine-tuning their privacy laws, among them, California, which passed the California Consumer Privacy Act (CCPA) in June 2018. Although it is less all-encompassing than the European Union’s recently enacted General Data Protection Regulation (GDPR), California’s law is considered to be the most comprehensive law of its kind so far in the United States.
In this POV, we discuss the CCPA, what it entails, how pharma marketers might be affected, and what they can do to prepare for the law’s 2020 implementation.